CKD-501, D759, D150

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

T2DM (Type 2 Diabetes Mellitus)Type 2 Diabetes Mellitus

Phase 1

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)

CompletedNCT04431687

Chong Kun Dang PharmaceuticalType 2 Diabetes Mellitus

Start: 2020-06-15End: 2020-10-26Updated: 2020-11-16

Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393

Chong Kun Dang PharmaceuticalT2DM (Type 2 Diabetes Mellitus)

Start: 2021-02-18End: 2021-04-05Target: 26Updated: 2021-01-12